Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARRIS - Another partner -- Ignore unavailable to you. Want to Upgrade?

To: David Bogdanoff who wrote (278)	12/3/1997 5:04:00 PM
From: Andrew H	Respond to of 353

>>Some of my old CTSL-recommended favorites (arris, abaxis, insite vision) are really on the floor compared to when I started following them, despite generally good progress. Can't blame it on the Asian flu!<< Didn't some hypist say this would be "the year of the biotech?" I am a firm believer that its always darkest before the dawn (until you die, that is). I remember last April things looked pretty bleak just before the biotech rally began in May. Actually, I think the Asian flu may be involved since in times of market uncertainty investors generally avoid stocks which have no earnings (most of our favorites). Now Asian worries have subsided somewhat. I agree things look pretty black for some of the old favorites, but that's what we get for investing in companies with brilliant futures but no earnings and high burn rates. (:>) More seriously, the IXB index is showing strong support at 310. Twice in the last year it as rallied to just below the 360 area. I expect the next rally will break through this level and take us to new highs. How long such new highs might hold is anyone's guess. With the current attitude toward biotechs, my guess is not long.